F. Nguyen-Tân

Phase III Trial of an Emulsion Containing Trolamine for the Prevention of Radiation Dermatitis in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck: Results of Radiation Therapy Oncology Group Trial 99-13

Elizabeth Elliott, James R. Wright, Ruth Swann et al. · Journal of Clinical Oncology · 2006 · 114 citations · Full text

Medicine, Oncology, Radiation Oncology +16

A phase III trial (RTOG 0129) of two radiation-cisplatin regimens for head and neck carcinomas (HNC): Impact of radiation and cisplatin intensity on outcome.

K. Kian Ang, Q. Zhang, Richard H. Wheeler et al. · Journal of Clinical Oncology · 2010 · 70 citations

Medicine, Oncology, Radiation Oncology +14

A Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination with Concurrent Cisplatin for Head and Neck Carcinomas (RTOG 0129): Report of Efficacy and Toxicity

K. Kian Ang, Thomas F. Pajak, Ralph A. Wheeler et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 35 citations · Full text

Medicine, Oncology, Cancer Drug Toxicity Management +15

The effect of age on outcome in prospective, phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- chemotherapy in locally advanced (LA) head and neck cancer (HNC).

Julie A. Kish, Qiang Zhang, Corey J. Langer et al. · Journal of Clinical Oncology · 2015 · 14 citations

Medicine, Oncology, Radiation Oncology +15